MONTREAL, CANADA–(Marketwired – July 14, 2015) – Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that COFEPRIS, Mexico’s health agency, has approved the 2mg/vial presentation of tesamorelin for the treatment […]